Opioid peptides have long been considered as neuropeptides or neurotransmitters. The more recent discovery of these same peptides in non-neuronal tissue suggests that the peptides may have autocrine, paracrine, or endocrine functions as well. The opioid peptides, enkephalins, dynorphins, and endorphins, have been found in isolated cardiac myocytes and heart tissue. This review will cover the recent literature on opioid peptides in respect to cardiac distribution, biochemistry, and function.
Get full access to this article
View all access options for this article.
References
1.
HughesJ, SmithTW, KosterlitzHW, FothergillLA, MorganBA, MorrisHR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature258: 577–579, 1975.
2.
UdenfriendS, KilpatrickDL. Biochemistry of the enkephalins and enkephalin-containing peptides. Arch Biochem Biophys221: 309–323, 1983.
3.
SirenA, FeuersteinG.The opioid system in circulatory control. News Physiol Sci7: 26–30, 1992.
4.
LundbergJM, HokfeltT, NilssonG, TereniusL, RehfeldJ, EldeR, SaidS.Peptide neurons in the vagus, splanchnic, and sciatic nerves. Acta Physiol Scand104: 499–501, 1978.
5.
TangJ, YangHYT, CostaE.Distribution of met-enkephalin-arg6-phe7 in various tissues of rats and guinea pigs. Neuropharmacol21: 595–600, 1982.
6.
HexumTD, RussenLR, BarronBA. Extraction of enkephalin-like peptides from splanchnic nerve. J Neurochem43: 1500–1503, 1985.
7.
BastiaensenE, MiserezB, De PotterW.Subcellular fractionation of bovine ganglion stellatum: Co-storage of noradrenaline, met-enkephalin, and neuropeptide Y in large ‘dense-cored’ vesicles. Brain Res442: 124–130, 1988.
8.
BarronBA, PierzchalaK, Van LoonGR. Source of stress-induced increase in plasma Met-enkephalin in rats: Contribution of adrenal medulla and/or sympathetic nerves. J Neuroendocrinol2: 381–388, 1990.
9.
RostovtsevAP, WilsonSP. Processing of proenkephalin in bovine chromaffin cells occurs in two phases. Mol Cell Endocrinol101: 277–285, 1994.
10.
JohanningK, MathisJP, LindbergI.Processing site blockade results in more efficient conversion of proenkephalin to active opioid peptides. J Biol Chem271: 27871–27878, 1996.
TangJ, ChouJ, ZhangAZ, YangHYT, CostE.Met5-enkephalin-arg6-phe7 and its receptor in lung. Life Sci32: 2371–2377, 1983.
13.
SpampinatoS, CanossaM, VenturaC, BachettiT, VenturiniR, BastagliL, BernardiP, FerriS.Heterogeneity of immunoreactive dynorphine B-like material in human, rat, rabbit, and guinea-pig heart. Life Sci48: 551–559, 1991.
14.
CanossaM, VenturaC, VaonaI, CarboniL, GuarnieriC, SpampinatoS.Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochim Biophys Acta172: 247–250, 1993.
15.
HowellsR, KilpatrickD, BaileyL, NoeM, UdenfriendS.Proenkephalin mRNA in rat heart. Proc Natl Acad Sci U S A83: 1960–1963, 1986.
16.
SpringhornJP, ClaycombWC. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol263: H1560–H1566, 1992.
17.
MillingtonWR, EvansVR, FormanLJ, BattieCN. Characterization of β-endorphin- and α-MSH-related peptides in rat heart. Peptides14: 1141–1147, 1993.
18.
FormanLJ, HockCE, HarwellM, Estilow-IsabellS.The results of exposure to immobilization, hemorrhagic shock, and cardiac hypertrophy on β-endorphin in rat cardiac tissue (43730). Proc Soc Exp Biol Med206: 124–130, 1994.
19.
MillingtonWR, RosenthalDW, Unal Cv Nyquist-BattieC.Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res43: 107–116, 1999.
20.
DumontM, LemaireS.Increased content of immunoreactive Leuenkephalin and alteration of δ-opioid receptor in hearts of spontaneously hypertensive rats. Neurosci Lett94: 114–118, 1988.
21.
OuelletteM, Brakier-GingrasL.Increase in the relative abundance of preproenkephalin, a messenger RNA in the ventricles of cardiomyopathic hamsters. Biochem Biophys Res Commun155: 449–454, 1988.
22.
ParadisP, DumontM, BelichardP, RouleauJL, LemaireS, Brakier-GingrasL.Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction. Biochem Cell Biol70: 593–598, 1992.
23.
AtionuA, SorensenK, WhitheadB, SingerD, CarterN.Ventricular expression and circulating levels of immunoreactive dynorphin in heart transplant recipients. Clin Sci85: 1–4, 1993.
24.
CaffreyJL, BoluytMO, YounesA, BarronBA, O'NeillL, CrowMT, LakattaEG. Aging, cardiac proenkephalin mRNA, and enkephalin in the Fisher 344 mice. J Mol Cell Cardiol26: 701–711, 1994.
25.
BarronBA, GuH, GauglJF, CaffreyJL. Screening for opioids in dog heart. J Mol Cell Cardiol24: 67–77, 1992.
26.
BarronBA, YoshishigeDA, KlineGP, GwirtzPA. Renovascular hypertension increases canine cardiac met-enkephalin-arg-phe and proenkephalin. Unpublished paper presented at International Narcotics Research Conference, Garmisch-Parten Kirchen, Germany, July 20–25, 1998.
27.
MateoZ, NapierL, GauglJF, BarronBA, CaffreyJL. Hemorrhage alters plasma and cardiac enkephalins and catecholamines in anesthetized dogs. Am J Physiol269: H2082–H2089, 1995.
28.
BarronBA, LaughlinMH, GwirtzPA. Exercise effect on canine and miniswine cardiac catecholamines and enkephalins. Med Sci Sports Exerc29: 1338–1343, 1997.
29.
MantelliL, AmeriniS, RubinoA, LeddaF.Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria. Eur J Pharmacol180: 325–330, 1990.
30.
MantelliL, CortiV, LeddaF.On the presence of opioid receptors in guinea-pig ventricular tissue. Gen Pharmacol18: 309–313, 1987.
31.
FuderH, BuderM, RiersH-D, RothacherG.On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.Naunyn Schmiedebergs Arch Pharmacol332: 148–155, 1986.
32.
GuH, BarronBA, GauglJF, CaffreyJL. Dynorphin, naloxone, and the overflow of norepinephrine overflow during cardiac nerve stimulation in the dog. Am J Physiol263: H153–H161, 1992.
33.
GuH, GauglJF, BarronBA, CaffreyJL. Naloxone enhances cardiac contractile responses to epinephrine without altering epinephrine uptake from plasma. Circ Shock32: 257–271, 1990.
34.
DumontM, LemaireS.Characterization of non-opioid [3H]dynorphin A-(1–13) binding site in the rat heart. J Mol Cell Cardiol25: 983–991, 1993.
35.
WongTM, LeeAYS, TaiKK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart: An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol22: 1167–1175, 1990.
36.
WongTM, LeeAYS. Chronic morphine treatment reduces the incidence of ventricular arrhythmias in the isolated rat heart induced by dynorphin1–13 or myocardial ischemia and reperfusion. Neurosci Lett. 77: 61–65, 1987.
37.
XiaQ, ShengJZ, TaiKK, WongTM. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. J Pharmacol268: 930–934, 1994.
38.
HoladayJW. Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Tox23: 541–594, 1983.
39.
FeuersteinG, SirenAL. The opioid system in cardiac and vascular regulation of normal and hypertensive states. Circulation75(Suppl I):I-125–I-129, 1987.
40.
ElaC, HasinY, EilamY.Opioid effects on contractility, Ca2+-transients, and intracellular pH in cultured cardiac myocytes. J Mol Cell Cardiol26: 599–613, 1993.
41.
WilliamsJR, EganTM, NorthRA. Enkephalin opens potassium channels on mammalian central neurones. Nature299: 74–77, 1982.
42.
AraujoDM, CollierB.Do presynaptic opiate receptors and α-adrenoceptors alter acetylcholine release from a sympathetic ganglion by a similar mechanism?Eur J Pharmacol139: 169–186, 1987.
43.
WangL, GintzlerAR. Bimodal opioid regulation of cyclic AMP formation: Implications for positive and negative coupling of opiate receptors to adenylyl cyclase. J Neurochem63: 1726–1730, 1994.
44.
JohnsonPS, WangJB, WangWF, UhlGR. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositiol turnover. Neuroreport5: 507–509, 1994.
45.
RhimH, MillerRJ. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the mice. J Neurosci14: 7608–7615, 1994.
46.
IngramSI, WilliamsJT. Opioid inhibition of Ih via adenylyl cyclase. Neuron13: 179–186, 1994.
47.
ChildersSR. Opioid receptor-coupled second messenger systems. Life Sci48: 1991–2003, 1991.
48.
VenturaC, GuarnieriC, SpurgeonHA, LakattaEG, CapogrossiMC. κ opioid receptor agonist causes an intracellular release of Ca2+ in cardiac myocytes and neuronal cells. Biophys J57: 294, 1990.
49.
TaiKK, BianCF, WongTM. κ-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci51: 909–913, 1992.
50.
LaurentS, MarshJD, SmithTW. Enkephalins increase cyclic adenosine monophosphate content, calcium uptake, and contractile state in cultured chick embryo heart cells. J Clin Invest77: 1436–1440, 1986.
51.
WollemannM, FarkasJ, TothG, BenyheS.Characterization of [3H]met-enkephalin-arg6-phe7 binding to opioid receptors in frog brain membrane preparations. J Neurochem63: 1460–1465, 1994.
52.
LovelaceJL, BarronBA, CaffreyJL. Differential degradation of methionine enkephalin (ME) and methionine enkephalin-arg-phe (MEAP) in canine myocardium, (abstract)Unpublished paper presented at Proc See Exp Biol Med Southwest Regional Meeting, San Antonio, Texas, October 17–18, 1997.
CaffreyJL, MateoZ, NapierLD, GauglJF, BarronBA. Intrinsic cardiac enkephalins inhibits vagal bradycardia in the dog. Am J Physiol268: H848–H955, 1995.
55.
NapierLD, StanfillA, YoshishigeDA, JacksonKE, BarronBA, CaffreyJL. Autonomic control of heart rate in dogs treated chronically with morphine. Am J Physiol275: H199–H210, 1998.
56.
BarronBA, HexumTD. Modulation of bovine adrenal gland secretion by etorphine and diprenorphine. Life Sci38: 935–940, 1986.
57.
ImaiN, KashikiM, WoolfPD, LiangC-S.Comparison of cardiovascular effects of μ- and δ-opioid receptor antagonists in dogs with congestive heart failure. Am J Physiol267: H912–H917, 1994.
58.
CaffreyJL, GauglJF, JonesCE. Local endogenous opiate activity in dog myocardium: Receptor blockade with naloxone. Am J Physiol248: H382–H388, 1985.
59.
HuangXD, LeeAYS, WongTM. Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs. Br J Pharmacol87: 475–477, 1986.
CaffreyJL, WooldridgeCB, GauglJF. Naloxone enhances the myocardial responses to isoproterenol in the dog isolated heart-lung. Am J Physiol250: H749–H754, 1986.
62.
VenturaC, BastagliL, BernardiP, CaldareraCM, GuarnieriC.Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenol. Biochim Biophys Acta987: 69–74, 1989.
63.
SzilagyiJE. Opioid modulation of baroreceptor reflex sensitivity in dogs. Am J Physiol252: H733–H737, 1987.
64.
DouglasH, KitchenI.Mechanisms involved in the cardiovascular responses to opioid products of proenkephalin in the anesthetised rat. Gen Pharmacol23: 269–277, 1992.
GuH, BarronBA, GauglJF, CaffreyJL. (+)Naloxone potentiates the inotropic effect of epinephrine. Circ Shock40: 206–211, 1993.
67.
KruminsSA, FadenAI, FeuersteinG.Opiate binding in rat hearts: Modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun127: 120–128, 1985.
68.
ChienGL, Van WinkleDM. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol28: 1895–1900, 1996.
69.
SchultzJJ, HsuAK, GrossGJ. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol29: 1355–1362, 1997.
70.
SchultzJJ, HsuAK, GrossGJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat. J Mol Cell Cardiol29: 2187–2195, 1997.
71.
SchultzJJ, HsuAK, GrossGJ. Ischemic preconditioning in the intact rat heart is mediated by δ1- but not μ or κ-opioid receptors. Circulation97: 1282–1289, 1998.
72.
SchultzJJ, HsuAK, NagaseH, GrossGJ. TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol274: H909–H914, 1998.
73.
WongSC, IngenitoAI. Influence of hypertension development on rat tail artery responses to opioid peptides. Pharmacology50: 40–50, 1995.
74.
YuXC, WangHX, ZhangWM, WongTM. Cross-talk between cardiac κ-opioid and β-adrenergic receptors in developing hypertensive rats. J Mol Cell Cardiol31: 597–605, 1999.
75.
BhargavaHN, MatwyshynGA, HanissianS, TejwaniGA. Opioid peptides in pituitary gland, brain regions, and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Brain Res440: 333–340, 1988.
76.
DumontM, OuelletteM, Brakier-GringrasL, LemaireS.Circadian regulation of the biosynthesis of cardiac met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci48: 1895–1902, 1991.
77.
BoluytM, YounesA, CaffreyJL, O'NeillL, BarronBA, CrowMT, LakattaEG. Age-associated increase in rat cardiac opioid production. Am J Physiol265: H212–H218, 1993.
78.
TsudaK, MasuyamaY.Presynaptic regulation of neurotransmitter release in hypertension. Clin Exp Pharmacol Physiol18: 455–467, 1991.
79.
Al'AbsiM, BuchanaT, LovalloWR. Pain perception and cardiovascular responses in men with positive parental history for hypertension. Psychophysiology33: 655–661, 1996.
